UNITEDHEALTH GROUP INCORPORATED (Delaware)UNH
Closing prices as of Oct 23, 2026Updated once daily after the US close — not a live quote.

$418.20

+11.21% past month

Notable price movement

  • Oct 23, 2026

    $418.09-1.62%

    UNH closed down 1.62%, in line with comparable hospital and medical service plan companies, which fell 1.74% on average, with 4 of 5 declining . Seeking Alpha published a story that CVS Caremark, Express Scripts and Optum Rx were targeted in a House investigation .

  • Oct 22, 2026

    $424.98+1.91%

    UnitedHealth rose 1.91% while comparable hospital and medical service plan companies gained 1.51% on average, with 4 of 5 rising . The move came alongside a broadly positive group session rather than standing apart from it .

  • Oct 21, 2026

    $417.00-0.54%

    UnitedHealth fell 0.54% while comparable Hospital & Medical Service Plans companies fell 1.11% on average, with all 5 lower . The decline was smaller than the group's and came alongside a shared sector drop.

  • Oct 20, 2026

    $419.26+3.04%

    UnitedHealth rose 3.04% as comparable Hospital & Medical Service Plans companies rose 3.14% on average, with all 5 of 5 higher . The gain came alongside a sector-wide advance rather than standing apart from it.

  • Oct 19, 2026

    $406.88+1.36%

  • Oct 16, 2026

    $401.43-1.29%

    UnitedHealth closed down 1.29%, in line with its comparable companies in Hospital & Medical Service Plans, which fell 1.52% on average that session . Four of the five peers fell and one rose . The move was largely shared with the group.

  • Oct 15, 2026

    $406.67+2.79%

    Comparable Hospital & Medical Service Plans companies rose 1.29% on average, with all 5 advancing . UnitedHealth's gain of 2.79% came alongside that sector move . Volume was 1.8x the trailing 20-session average, and the session ranged from 400.00 to 414.12 .

Closing prices for UNH. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Prices and financial data are historical and provided for research only. Not investment advice.